Coal mining and lung disease in the 21st century.


Journal

Current opinion in pulmonary medicine
ISSN: 1531-6971
Titre abrégé: Curr Opin Pulm Med
Pays: United States
ID NLM: 9503765

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 10 12 2019
medline: 22 8 2020
entrez: 10 12 2019
Statut: ppublish

Résumé

To review the impact of coal mining and resurgence of coal workers' pneumoconiosis (CWP) in 21st century and effect of ambient air pollution on lung function. At the beginning of 21st century, statistics by National Institute for Occupational Safety and Health showed a steep rise in pneumoconiosis. This was followed by numerous epidemiologic and pathologic studies that confirmed increasing CWP prevalence as well as disease in younger miners and those with a shorter mining tenure. Recent studies have demonstrated that poor dust control in mines, a relative shift in composition of the coal mine dust, small sized mines and increase in surface mining are all possible contributors to this resurgence. There is also growing literature evaluating the effects of worsening air pollution on health, including decreasing lung function and development of emphysema, worsening quality of life measures and lung cancer. This irreversible but preventable disease currently haunts approximately 60 000 miners across United States and millions across the world. Its resurgence despite the strict dust regulations is a setback from the public health standpoint. The continued reliance on coal for energy will continue to place coal miners at danger of developing disease as well as the world.

Identifiants

pubmed: 31815751
doi: 10.1097/MCP.0000000000000653
pii: 00063198-202003000-00006
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

135-141

Références

Federal Coal Mine Health and Safety Act of 1969 (Public Law 91-173, amended in 1977 and 2006). Available at: https://arlweb.msha.gov/solicitor/coalact/69act.htm. [Accessed 14 August 2019]
Blackley DJ, Halldin CN, Laney AS. Resurgence of a debilitating and entirely preventable respiratory disease among working coal miners. Am J Respir Crit Care Med 2014; 190:708–709.
Stansbury RC. Progressive massive fibrosis and coal mine dust lung disease: the continued resurgence of a preventable disease. Ann Am Thorac Soc 2018; 15:1394–1396.
Centers for Disease Control and Prevention (CDC). Pneumoconiosis prevalence among working coal miners examined in federal chest radiograph surveillance programs: United States, 1996–2002. MMWR Morb Mortal Wkly Rep 2003; 52:336–340.
Attfield MD. Centers for Disease Control and Prevention. Current intelligence bulletin 64: coal mine dust exposures and associated health outcomes - a review of information published since 1995. DHHS (NIOSH) Publication No. 2011–172; 2011 April
Antao V, Petsonk EL, Attfield MD. Advanced cases of coal workers’ pneumoconiosis: two counties, Virginia, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:909–913.
Laney AS, Attfield MD. Examination of potential sources of bias in the US Coal Workers’ Health Surveillance Program. Am J Public Health Am J Public Health 2014; 104:165–170.
Antao VC, Petsonk EL, Sokolow LZ, et al. Rapidly progressive coal workers’ pneumoconiosis in the United States: geographic clustering and other factors. Occup Environ Med 2005; 62:670–674.
Cohen RA, Green F, Abraham JL, et al. Coal mine dust lung disease among miners killed in the upper big branch disaster: a systematic review of lung pathology. Am J Respir Crit Care Med 2013; 187:A6063.
Blackley DJ, Crum JB, Halldin CN, et al. Resurgence of progressive massive fibrosis in coal miners: Eastern Kentucky, 2016. MMWR Morb Mortal Wkly Rep 2016; 65:1385–1389.
Mazurek JM, Wood J, Blackley DJ, Weissman DN. Coal workers’ pneumoconiosis-attributable years of potential life lost to life expectancy and potential life lost before age 65 years: United States, 1999-2016. MMWR Morb Mortal Wkly Rep 2018; 67:819–824.
Almberg KS, Halldin CN, Blackley DJ, et al. Progressive massive fibrosis resurgence identified in U.S. coal miners filing for black lung benefits, 1970-2016. Ann Am Thorac Soc 2018; 15:1420–1426.
Blackley DJ, Halldin CN, Laney AS. Continued Increase in prevalence of coal workers’ pneumoconiosis in the United States, 1970-2017. Am J Public Health 2018; 108:1220–1222.
Beer C, Kolstad HA, Søndergaard K, et al. A systematic review of occupational exposure to coal dust and the risk of interstitial lung diseases. Eur Clin Respir J 2017; 4:1–11.
Petsonk EL, Rose C, Cohen R. Coal mine dust lung disease. New lessons from old exposure. Am J Respir Crit Care Med 2013; 187:1178–1185.
Altınsoy B, Öz II, Erboy F, et al. Emphysema and airflow obstruction in non-smoking coal miners with pneumoconiosis. Med Sci Monit 2016; 22:4887–4893.
Cohen RA, Patel A, Green FH. Lung disease caused by exposure to coal mine and silica dust. Semin Respir Crit Care Med 2008; 29:651–661.
Wang H, Li Y, Li J. Autopsies of five coal workers with pleural plaque. Zhonghua Yu Fang Yi Xue Za Zhi 1997; 31:169–171.
Walton WH, Dodgson J, Hadden GG, Jacobsen M. The effect of quartz and other noncoal dusts in coal workers’ pneumoconiosis. Part I: Epidemiological studies. Inhaled Part 1975; 4 Pt 2:669–690.
United States National Institute for Occupational Safety and Health. Criteria for a Recommended Standard — Occupational Exposure to Respirable Coal Mine Dust. DHHS (NIOSH) Publication No. 95-102; 1995 September.
Wade WA, Petsonk EL, Young B, Mogri I. Severe occupational pneumoconiosis among West Virginian coal miners: one hundred thirty-eight cases of progressive massive fibrosis compensated between 2000 and 2009. Chest 2011; 139:1458–1462.
Yorio PL, Laney AS, Halldin CN. Interstitial lung diseases in the U.S. mining industry: using MSHA data to examine trends and the prevention effects of compliance with health regulations, 1996-2015. Risk Anal 2018; 38:1962–1971.
Blackley DJ, Halldin CN, Wang ML, Laney AS. Small mine size is associated with lung function abnormality and pneumoconiosis among underground coal miners in Kentucky, Virginia and West Virginia. Occup Environ Med 2014; 71:690–694.
Doney B, Blackley D, Hale JM, et al. Respirable coal mine dust in underground mines, United States, 1982-2017. Am J Ind Med 2019; 62:478–485.
Go L, Lowers HA, Sanyal S, et al. Mineralogic analysis of lung tissue from a former coal miner with rapidly progressive pneumoconiosis and progressive massive fibrosis. Am J Respir Crit Care Med 2019; 199:A1820.
Najmuddin A, Petsonk EL, Regier R, Young B, Tramma S, Cohen R, McNeil S, Green FHY, Abraham J, Churg A. Preliminary report of novel pathologic findings in patients with rapidly progressive pneumoconiosis. Presented. Inhaled Particles XI, 23-25 September 2013, Nottingham Trent University Conference Centre.
Shriver TE, Bodenhamer A. The enduring legacy of black lung: environmental health and contested illness in Appalachia. Sociol Health Illn 2018; 40:1361–1375.
Reynolds LE, Blackley DJ, Colinet JF, et al. Work practices and respiratory health status of Appalachian coal miners with progressive massive fibrosis. J Occup Environ Med 2018; 60:e575–e581.
Sood A, Shore X, Myers O, et al. Among all miners, coal miners demonstrate a disproportionately high prevalence of obstructive spirometric abnormality and chronic bronchitis. J Occup Environ Med 2019; 61:328–334.
Blackley DJ, Halldin CN, Laney AS. Continued increase in lung transplantation for coal workers’ pneumoconiosis in the United States. Am J Ind Med 2018; 61:621–624.
Wilt JL, Banks DE, Weissman DN, et al. Reduction of lung dust burden in pneumoconiosis by whole-lung lavage. J Occup Environ Med 1996; 38:619–624.
Dempsey TM, Sangaralingham LR, Yao X, et al. Clinical effectiveness of antifibrotic medications for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2019; 200:168–174.
Cromar KR, Gladson LA, Ghazipura M, Ewart G. Estimated excess morbidity and mortality associated with air pollution above American Thoracic Society-recommended Standards, 2013-2015. American Thoracic Society and Marron Institute Report. Ann Am Thorac Soc 2018; 15:542–551.
Han S, Hong C, Harvey MA, et al. Focusing on coal workers’ lung diseases: a comparative analysis of China, Australia, and the United States. Int J Environ Res Public Health 2018; 15:2565.
Anderson HR. Holgate ST, Samet JM, Koren HS, Maynard RL. Health effects of air pollution episodes. Air pollution and health. New York: Academic Press; 1999. 461–482.
Krishnan S, Panacherry S. Asthma, environment and pollution: where the rubber hits the road. Indian J Pediatr 2018; 85:893–898.
Liu C, Chen R, Sera F, et al. Ambient particulate air pollution and daily mortality in 652 cities. N Engl J Med 2019; 381:705–715.
Chen R, Yin P, Meng X, et al. Associations between coarse particulate matter air pollution and cause-specific mortality: a nationwide analysis in 272 Chinese cities. Environ Health Perspect 2019; 127:1–9.
Wang M, Aaron C, Madrigano J, et al. Association between long-term exposure to ambient air pollution and change in quantitatively assessed emphysema and lung function. JAMA 2019; 322:546–556.
Ebi KL, Ogden NH, Semenza JC, Woodward A. Detecting and attributing health burdens to climate change. Environ Health Perspect 2017; 125:085004–185004.
Mitchell D, Heaviside C, Vardoulakis S, et al. Attributing human mortality during extreme heat waves to anthropogenic climate change. Environ Res Lett 2016; 11:074006–174006.
World Health Organization. Quantitative risk assessment of the effects of climate change on selected causes of death, 2030 s and 2050 s. 2014. Available at: https://apps.who.int/iris/bitstream/handle/10665/134014/9789241507691_eng.pdf?sequence=1&isAllowed=y Accessed 19 September, 2019.
Lelieveld J, Klingmüller K, Pozzer A, et al. Effects of fossil fuel and total anthropogenic emission removal on public health and climate. Proc Natl Acad Sci U S A 2019; 116:7192–7197.
Shindell D, Smith CJ. Climate and air-quality benefits of a realistic phase-out of fossil fuel. Nature 2019; 573:408–411.

Auteurs

Rachel Leonard (R)

Department of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, West Virginia University, Morgantown, West Virginia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH